Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study

dc.contributor.authorHanwella, Raveen
dc.contributor.authorWijesundera, H.
dc.contributor.authorDe Silva, V.A.
dc.date.accessioned2025-11-12T08:42:50Z
dc.date.issued2013
dc.description.abstractMany studies have shown that the prevalence of smoking in schizophrenia is higher than in the general population. Biological, psychological and social factors influence smoking in patients with schizophrenia. Methods: The study was carried out in psychiatry outpatient clinics in a tertiary care hospital in Sri Lanka. Every third patient was selected using systematic sampling from patients diagnosed with schizophrenia according to ICD-10 clinical criteria. Smoking behaviours were assessed using self-reports. Severity of illness was assessed using Brief Psychiatric Rating Scale (BPRS). Fagerstrom Test for Nicotine Dependence assessed level of dependence. Readiness to Change Questionnaire assessed motivation to change smoking behaviour.
dc.identifier.citationWijesundera, H., Hanwella, R. & de Silva, V.A. Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study. Ann Gen Psychiatry 13, 7 (2014). https://doi.org/10.1186/1744-859X-13-7
dc.identifier.urihttps://doi.org/10.1186/1744-859X-13-7
dc.identifier.urihttps://archive.cmb.ac.lk/handle/70130/8149
dc.language.isoen
dc.publisherSpringer Nature
dc.subjectNicotine
dc.subjectSchizophrenia
dc.subjectClozapine
dc.subjectOlanzapine
dc.titleAntipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
02.pdf
Size:
68.69 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections